A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines

Journal of Inorganic Biochemistry

Volumn 104, Issue 5, 2010, Pages 503-511

  Vessières, Anne ^a   Corbet, Cyril ^b,c   Heldt, Jan Martin ^a   Lories, Nicolas ^d   Jouy, Nathalie ^e   Laïos, Ioanna ^d   Leclercq, Guy ^d   Jaouen, Gérard ^a   Toillon, Robert Alain ^b,c,d  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

^d JULES BORDET INSTITUTE   (Belgium)

^e IFR114 IMPRT   (France)

Author keywords

Bioorganometallic chemistry; Breast cancer; Estrogen; Ferrocene; Iron; Tamoxifen

Indexed keywords

4 HYDROXYTAMOXIFEN; CYTOTOXIC AGENT; ESTROGEN RECEPTOR ALPHA; FERROCIFEN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS;

EID: 77950690724     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2009.12.020     Document Type: Article

References (42)

1. Lacroix M., Toillon R.A., Leclercq G. Endocr. Relat. Cancer 2004, 11:497-522.
2. Klinge C.M. Nucleic Acids Res. 2001, 29:2905-2919.
3. Loi S. Eur. J. Cancer 2008, 44:2813-2818.
4. Lin N.U., Winer E.P. J. Clin. Oncol. 2008, 26:798-805.
5. Chargari C., Toillon R.A., Macdermed D., Castadot P., Magné N. Lancet Oncol. 2009, 10:53-60.
6. MacGregor J.I., Jordan V.C. Pharmacol. Rev. 1998, 50:151-196.
7. Weng S.C., Kashida Y., Kulp S.K., Wang D., Brueggemeier R.W., Shapiro C.L., Chen C.S. Mol. Cancer Ther. 2008, 7:800-808.
8. Nagahara Y., Shiina I., Nakata K., Sasaki A., Miyamoto T., Ikekita M. Cancer Sci. 2008, 99:608-614.
9. Lagadec C., Adriaenssens E., Toillon R.A., Chopin V., Romon R., Van Coppenolle F., Hondermarck H., Le Bourhis X. Oncogene 2008, 27:1472-1477.
10. Yao D., Zhang F., Yu L., Yang Y., van Breemen R.B., Bolton J.L. Chem. Res. Toxicol. 2001, 14:1643-1653.
11. Mandlekar S., Kong A.N. Apoptosis 2001, 6:469-477.
12. Tian F., Wu H., Li Z., Wang N., Huang J., Li C., Xie F. Cancer Invest. 2009, 18:1.
13. Wang Y., He Q.Y., Chen H., Chiu J.F. Exp. Cell Res. 2007, 15:357-368.
14. Chisholm K., Bray B.J., Rosengren R.J. Anticancer Drugs 2004, 15:889-897.
15. Wozniak K., Kolacinska A., Blasinska-Morawiec M., Morawiec-Bajda A., Morawiec Z., Zadrozny M., Blasiak J. Arch. Toxicol. 2007, 81:519-527.
16. Klinge C.M. J. Cell Biochemistry 2008, 105:1342-1351.
17. Jaouen G., Top S., Vessières A., Leclercq G., Quivy J., Jin L., Croisy A. CR Acad. Sci. Paris Série IIc 2000, 89-93.
18. Vessières A., Top S., Beck W., Hillard E., Jaouen G. Dalton Trans. 2006, 4:529-541.
19. Nguyen A., Vessières A., Hillard E., Top S., Pigeon P., Jaouen G. Chimia 2007, 61:716-725.
20. Top S., Vessières A., Leclercq G., Quivy J., Tang J., Vaissermann J., Huché M., Jaouen G. Chem. Eur. J. 2003, 9:5223-5236.
21. Toillon R.A., Magné N., Laïos I., Castadot P., Kinnaert E., Van Houtte P., Desmedt C., Leclercq G., Lacroix M. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:1187-1200.
22. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. Proc. Natl. Acad. Sci. USA 1995, 92:9363-9367.
23. Pons M., Gagne D., Nicolas J.C., Mehtali M. Biotechniques 1990, 9:450-459.
24. Laïos I., Journé F., Nonclercq D., Vidal D.S., Toillon R.A., Laurent G., Leclercq G. J. Steroid Biochem. Mol. Biol. 2005, 94:347-359.
25. Chen G.G., Zeng Q., Tse G.M. Med. Res. Rev. 2008, 28:954-974.
26. Lacroix M., Leclercq G. Breast Cancer Res. Treat. 2004, 83:249-289.
27. Blick T., Widodo E., Hugo H., Waltham M., Lenburg M.E., Neve R.M., Thompson E.W. Clin. Exp. Metastasis 2008, 25:629-642.
28. P. De Cremoux, Personal Communication.
29. Essmann F., Engels I.H., Tozke G., Schulze-Osthoff K., Jänicke R.U. Cancer Res. 2004, 64:7065-7072.
30. Toillon R.A., Magné N., Laïos I., Lacroix M., Duvillier H., Lagneaux L., Devriendt D., Van Houtte P., Leclercq G. Breast Cancer Res.Treat. 2005, 93:207-215.
31. Iwasa H., Han J., Ishikawa F. Genes Cells 2003, 8:131-144.
32. Bartosz G. Clin. Chim. Acta 2006, 368:53-76.
33. Nazarewicz R.R., Zenebe W.J., Parihar A., Larson S.K., Alidema E., Choi J., Ghafourifar P. Cancer Res. 2007, 67:1282-1290.
34. Osella D., Mahboobi H., Colangelo D., Caviglilio G., Vessières A., Jaouen G. Inorg. Chim. Acta 2005, 358:1993-1998.
35. Prossnitz E.R., Oprea T.I., Sklar L.A., Arterburn J.B. J. Steroid Biochem. Mol. Biol. 2008, 109:350-353.
36. Tabbì G., Cassino C., Cavigiolio G., Colangelo D., Ghiglia A., Viano I., Osella D. J. Med. Chem. 2002, 45:5786-5796.
37. Kallio A., Zheng A., Dahllund J., Heiskanen K.M., Härkönen P. Apoptosis 2005, 10:1395-1410.
38. Michard Q., Jaouen G., Vessières A., Bernard B.A. J. Inorg. Biochem. 2008, 102:1980-1985.
39. Hillard E.A., Vessières A., Thouin L., Jaouen G., Amatore C. Angew. Chem., Int. Ed. 2006, 45:285-290.
40. Hamels D., Dansette P., Hillard E.A., Top S., Vessières A., Herson P., Jaouen G., Mansuy D. Angew. Chem., Int. Ed. 2009, 48:9124-9126.
41. de Medina P., Payré B., Boubekeur N., Bertrand-Michel J., Tercé F., Silvente-Poirot S., Poirot M. Cell Death Differ. 2009, 16:1372-1384.
42. Nguyen A., Vessières A., Hillard E.A., Top S., Pigeon P., Jaouen G. Chimia 2007, 61:716-724.